Chair: Nicola Scott
The GSK Biostatistics team has successfully used Bayesian Dynamic Borrowing (BDB) in a commercial setting, which allows for the re-use of external data, synthesising new and existing data to increase efficiency whilst maintaining rigorous standards for regulatory decision making. The judging panel was impressed by the culmination of years of work invested in this project – starting with the development and publication of innovative methodology, followed by diligent efforts to communicate this methodology to regulators and stakeholders. The acceptance of Bayesian approaches by regulators is a big step forward, widely acknowledged within the industry and beyond. The award presentation took place at the PSI annual conference in Amsterdam, where Nicky Best and Andrea Callegaro collected the award on behalf of the Biostatistics team.
Nicky Best, Andrea Callegaro, Dawn Edwards and Jodie Crawford